Harvard Bioscience Inc (HBIO) — Cash Flow Reinvestment Rate
Harvard Bioscience Inc (HBIO) has a Cash Flow Reinvestment Rate of 0.67x as of September 2025, reinvesting $555.00K (capex $207.00K plus investments $-348.00K) from operating cash flow of $830.00K. Explore reinvestment intensity of Harvard Bioscience Inc to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Harvard Bioscience Inc Cash Flow Reinvestment Rate (1999–2024)
Historical reinvestment intensity for Harvard Bioscience Inc across 26 annual periods. Also explore HBIO total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Harvard Bioscience Inc (1999–2024)
Year-by-year capital reinvestment analysis for Harvard Bioscience Inc. For live market cap and broader valuation context, see Harvard Bioscience Inc market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 3.20x | $4.61 Million | $1.44 Million | $3.26 Million | ▲ +1266.6% |
| 2023 | 0.23x | $3.28 Million | $14.03 Million | $2.31 Million | ▼ -91.5% |
| 2022 | 2.76x | $3.18 Million | $1.15 Million | $1.59 Million | ▲ +29.5% |
| 2021 | 2.13x | $2.69 Million | $1.26 Million | $1.34 Million | ▲ +678.8% |
| 2020 | 0.27x | $2.55 Million | $9.33 Million | $1.15 Million | ▲ +52.4% |
| 2019 | 0.18x | $1.45 Million | $8.05 Million | $1.22 Million | ▼ -99.2% |
| 2018 | 23.37x | $54.78 Million | $2.34 Million | $986.00K | ▲ +1267.1% |
| 2017 | 1.71x | $1.81 Million | $1.06 Million | $890.00K | ▲ +497.2% |
| 2016 | 0.29x | $1.54 Million | $5.38 Million | $1.48 Million | ▼ -93.2% |
| 2015 | 4.22x | $2.98 Million | $705.00K | $2.98 Million | ▲ +816.7% |
| 2014 | 0.46x | $2.00 Million | $4.35 Million | $2.00 Million | ▲ +11.4% |
| 2013 | 0.41x | $1.68 Million | $4.06 Million | $1.68 Million | ▲ +82.1% |
| 2012 | 0.23x | $1.83 Million | $8.06 Million | $1.83 Million | ▼ -4.3% |
| 2011 | 0.24x | $1.51 Million | $6.35 Million | $1.51 Million | ▲ +245.5% |
| 2010 | 0.07x | $844.00K | $12.29 Million | $844.00K | ▼ -17.6% |
| 2009 | 0.08x | $1.38 Million | $16.51 Million | $1.38 Million | ▼ -41.4% |
| 2008 | 0.14x | $1.31 Million | $9.20 Million | $1.31 Million | ▲ +18.0% |
| 2007 | 0.12x | $1.45 Million | $12.05 Million | $1.45 Million | ▼ -57.8% |
| 2006 | 0.29x | $2.39 Million | $8.36 Million | $2.39 Million | ▲ +34.9% |
| 2005 | 0.21x | $1.10 Million | $5.20 Million | $1.10 Million | ▼ -19.6% |
| 2004 | 0.26x | $3.01 Million | $11.44 Million | $3.01 Million | ▼ -60.4% |
| 2003 | 0.67x | $1.35 Million | $2.03 Million | $1.35 Million | ▼ -59.3% |
| 2002 | 1.63x | $1.31 Million | $799.46K | $1.31 Million | ▲ +264.0% |
| 2001 | 0.45x | $1.84 Million | $4.10 Million | $1.84 Million | ▲ +53.1% |
| 2000 | 0.29x | $629.52K | $2.15 Million | $629.52K | ▲ +158.2% |
| 1999 | 0.11x | $332.47K | $2.93 Million | $332.47K | — |